Digital Tech & Trials: Biostats and medical writing There are many outputs produced during a clinical trial, and one of the most crucial is the Clinical Study Report (CSR).
News Private equity firms play 'pass the Parexel' with $8.5bn han... Four years after being taken private, Parexel has been sold again, with Goldman Sachs' private equity arm and EQT paying $8.5 billion to claim ownership of the contract research organisatio
Partner Content Partner Content The rise of wearable technology for clinical trials: insight... The rise of wearable technology for clinical trials
Events Partner Content 10th annual Adaptive Designs in Clinical Trials Adaptive Designs in Clinical Trials 2018
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.